The Detainee's Two Bodies: Intellectual Property and Fugitivity at Guantánamo Bay

Authors: Nadiminti, Kalyan

Source: Humanity: An International Journal of Human Rights, Humanitarianism, and Development. 13(3):343-366

Availability: https://muse.jhu.edu/article/876519

"A Betrayal of Everything": The Law of the Family in Jhumpa Lahiri's The Lowland

Authors: Nadiminti, Kalyan

Source: Journal of Asian American Studies. 21(2):239-262

Availability: https://muse.jhu.edu/article/697018

Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704

Authors: Sorror, Mohamed L. ^{1, 2, ∗}, Saber, Wael ^{3, 4}, Logan, Brent ^{3, 4}, Geller, Nancy ⁵, Bellach, Anna ⁵, Kou, Jianqun ^{3, 4}, Wood, William ⁶, McCarty, John M. ⁷, Knight, Thomas G. ⁸, Runaas, Lyndsey ³, Johnston, Laura ⁹, Walston, Jeremy ¹⁰, Nakamura, Ryotaro ¹¹, Jarrett, Lori ¹, Mishra, Asmita ¹², Uberti, Joseph ¹³, Dahi, Parastoo B. ^{14, 15}, Saultz, Jennifer N. ¹⁶, McCurdy, Shannon R. ¹⁷, Morris, Lawrence E. ¹⁸, Imus, Philip H. ¹⁹, Hogan, William J. ²⁰, Nadiminti, Kalyan ²¹, Bhatt, Vijaya Raj ²², Olin, Rebecca ²³, Maakaron, Joseph ²⁴, Sobecks, Ronald ²⁵, Wall, Sarah A. ²⁶, Mattila, Deborah ^{4, 27}, Protz, Bailey ^{4, 27}, Devine, Steven M. ^{4, 27}, Horowitz, Mary M. ^{3, 4}, Artz, Andrew S. ¹¹

Source: In Blood Advances February 2025

Menin inhibitors for the treatment of acute myeloid leukemia: challenges and opportunities ahead.

Authors: Nadiminti, Kalyan V. G.¹ (AUTHOR) knadimin@medicine.wisc.edu, Sahasrabudhe, Kieran D.¹ (AUTHOR), Liu, Hongtao¹ (AUTHOR)

Source: Journal of Hematology & Oncology. 11/18/2024, Vol. 17 Issue 1, p1-16. 16p.

Subject Terms: *ACUTE myeloid leukemia, *VENETOCLAX, *DRUG resistance, *CYTARABINE

This result is not displayed to guests.
Login for full access.

Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation

Authors: You, Xiaona ^*, Liu, Fabao ^*, Binder, Moritz ^*, Vedder, Alexis ^*, Lasho, Terra, Wen, Zhi, Gao, Xin, Flietner, Evan, Rajagopalan, Adhithi, Zhou, Yun, Finke, Christy, Mangaonkar, Abhishek, Liao, Ruiqi, Kong, Guangyao, Ranheim, Erik A., Droin, Nathalie, Hunter, Anthony M., Nikolaev, Sergey, Balasis, Maria, Abdel-Wahab, Omar, Levine, Ross L., Will, Britta, Nadiminti, Kalyan Vara Ganesh, Yang, David, Geissler, Klaus, Solary, Eric, Xu, Wei, Padron, Eric ^*, Patnaik, Mrinal M. ^*, Zhang, Jing ^*

Source: In Blood 17 February 2022 139(7):1066-1079

Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia.

Authors: Banaszak, Lauren G., Cabral, Paloma L., Smith-Simmer, Kelcy, Hassan, Ayesha, Brunner, Matthew, Fallon, Michael, Shoger, Kyle, Lovrien, Lauren, Golner, Danielle, Zurbriggen, Luke, Mattison, Ryan, Gahvari, Zhubin, Hall, Aric, Nadiminti, Kalyan, Reinig, Erica, Churpek, Jane E.

Source: JCO Precision Oncology; 12/1/2024, Vol. 8, p1-16, 16p

Subject Terms: MYELODYSPLASTIC syndromes, ACUTE myeloid leukemia, GENETIC counseling, GENETIC models, GENETIC testing

The Global Program Era : Contemporary International Fiction in the American Creative Economy

Authors: NADIMINTI, KALYAN

Source: NOVEL: A Forum on Fiction, 2018 Nov 01. 51(3), 375-398.

Access URL: https://www.jstor.org/stable/27158395

Histopathologic evidence of chimeric antigen receptor T‐cell therapy in lesions of B‐cell lymphoblastic leukemia cutis.

Authors: Nihal, Aman, Comstock, Jeanette R., Bennett, Daniel D., Mattison, Ryan J., Nadiminti, Kalyan Vara Ganesh, Keenan, Thomas

Source: Journal of Cutaneous Pathology; Aug2024, Vol. 51 Issue 8, p562-564, 3p

Subject Terms: CHIMERIC antigen receptors, LYMPHOBLASTIC leukemia, ANTIGEN receptors, B cells, T cells, CYTOKINE release syndrome

This result is not displayed to guests.
Login for full access.

Haploidentical Donor Transplantation with Posttransplantation Cyclophosphamide in Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Institutional Collaboration of 14 Centers

Authors: Jain, Tania, Tsai, Hua-Ling ^*, Elmariah, Hany, Vachhani, Pankit ^*, Karantanos, Theodoros, Wall, Sarah A, Gondek, Lukasz P., Bashey, Asad, Keyzner, Alla, Grunwald, Michael R., Abedin, Sameem, Nadiminti, Kalyan VG, Iqbal, Madiha, Gerds, Aaron T., Viswabandya, Auro ^*, McCurdy, Shannon R ^*, Al Malki, MHD Monzr M., Varadhan, Ravi ^*, Ali, Haris, Gupta, Vikas, Jones, Richard J., Otoukesh, Salman ^*

Source: In Blood 15 November 2022 140 Supplement 1:7731-7733

Impact of Early Hospitalization, Medical Comorbidities and Allogeneic Stem Cell Transplantation on Survival in Acute Myeloid Leukemia Patients Treated with Venetoclax Based Therapy - a Single Institution Experience from an Academic Center

Authors: Williams, Emma E ^*, McQuinn, Danielle ^*, Banaszak, Lauren G., Ninos, Cameron ^*, Mattison, Ryan J., Gahvari, Zhubin, Hall, Aric C. ^*, Fallon, Michael J ^*, Nadiminti, Kalyan VG

Source: In Blood 15 November 2022 140 Supplement 1:6099-6101

t(15; 17) associated with primary myelofibrosis: a case report of an unusual clinical presentation and diagnostic dilemma.

Authors: Nadiminti, Kalyan (AUTHOR), Silverman, Margarida (AUTHOR), Bhagavathi, Sharathkumar (AUTHOR), Vikas, Praveen (AUTHOR)

Source: OncoTargets & Therapy. Jul2019, Vol. 12, p5449-5455. 7p.

Subject Terms: *MYELOFIBROSIS, *REVERSE transcriptase polymerase chain reaction, *ACUTE promyelocytic leukemia, *RETINOIC acid receptors, *STEM cell transplantation, *BONE marrow

The Detainee's Two Bodies: Intellectual Property and Fugitivity at Guantánamo Bay.

Authors: Nadiminti, Kalyan

Source: Humanity: An International Journal of Human Rights, Humanitarianism & Development; Winter2022, Vol. 13 Issue 3, p1-25, 25p

Full Body Screening Computed Tomography Prior to Allogeneic Hematopoietic Stem Cell Transplantation: A Single Institution Experience from an Academic Center

Authors: McQuinn, Danielle, Racki, Lauren, Kenkre, Vaishalee P, Brunner, Matthew James, Gahvari, Zhubin J., Mattison, Ryan J, Hall, Aric C., Nadiminti, Kalyan

Source: In Blood 28 November 2023 142 Supplement 1:378-378

The Composite Health Risk Assessment Model (CHARM) to Predict 1-Year Non-Relapse Mortality (NRM) Among Older Recipients of Allogeneic Transplantation: A Prospective BMT-CTN Study 1704

Authors: Artz, Andrew, Logan, Brent R., Saber, Wael, Geller, Nancy, Bellach, Anna, Kou, Jianqun, Wood, William, McCarty, John M., Knight, Thomas G., Runaas, Lyndsey, Johnston, Laura, Walston, Jeremy, Nakamura, Ryotaro, Schuler, Tammy, Mishra, Asmita, Uberti, Joseph, Dahi, Parastoo B., Saultz, Jennifer N., McCurdy, Shannon R, Morris, Lawrence, Imus, Philip, Hogan, William J., Nadiminti, Kalyan, Bhatt, Vijaya Raj, Mattila, Deborah, Protz, Bailey, Devine, Steven M., Horowitz, Mary M., Sorror, Mohamed

Source: In Blood 2 November 2023 142 Supplement 1:109-109

This result is not displayed to guests.
Login for full access.

VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma.

Authors: Nadiminti, Kalyan^1,2, Abbi, Kamal Kant Singh^2,3, Mott, Sarah L.², Dozeman, Lindsay², Tricot, Annick², Schultz, Allyson², Behrends, Sonya^2,3, Zhan, Fenghuang^2,3, Tricot, Guido^2,3 guido-tricot@uiowa.edu

Source: OncoTargets & Therapy. Jan2017, Vol. 10, p217-226. 10p.

Subject Terms: *MELPHALAN, *MULTIPLE myeloma treatment, *CANCER relapse, *STEM cell transplantation, *DRUG efficacy, *DRUG toxicity

A Quality Improvement Initiative to Improve Implementation of Guideline-Concordant Hereditary Myeloid Malignancy Syndrome Evaluation

Authors: Banaszak, Lauren G., Cabral, Paloma ^*, Smith-Simmer, Kelcy ^*, Hassan, Ayesha, Brunner, Matthew J ^*, Fallon, Michael J ^*, Lovrien, Lauren ^*, Golner, Danielle ^*, Zurbriggen, Luke, Mattison, Ryan J., Gahvari, Zhubin, Hall, Aric C. ^*, Nadiminti, Kalyan VG, Reinig, Erica, Churpek, Jane

Source: In Blood 15 November 2022 140 Supplement 1:10828-10829

A novel Iowa–Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction.

Authors: Nadiminti, Kalyan, Langer, Kimberly, Shabbir, Ehsan, Hefazi, Mehrdad, Dozeman, Lindsay, Jethava, Yogesh, Loeffler, Bradley, AlKhateeb, Hassan B., Litzow, Mark, Patnaik, Mrinal, Shah, Mithun, Hogan, William, Farooq, Umar, Silverman, Margarida, Mott, Sarah L.

Source: Blood Cancer Journal; Nov2021, Vol. 11 Issue 11, p1-9, 9p

Subject Terms: STEM cell transplantation, SURVIVAL rate, HEMATOPOIETIC stem cell transplantation, TREATMENT effectiveness, CELL survival